Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — Q2 2024 Earnings Presentation
33 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Aug 13, 2024
Slide 1: Q2 2024 Investor Presentation
Q2 2024 Investor Presentation As of 13 August 2024
Slide 2: Disclaimer
DISCLAIMER Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 3: Presenting Team
PRESENTING TEAM Ziyad Al Dahami Faisal Al Nassar Esam Al Mashloum Head of Investor Relations and Treasury Chief Executive Officer Vice President, Finance Q2 2024 Investor Presentation 3 August 2024
Slide 4: Agenda
Agenda Financial Performance Projects Update Operational Highlights Appendix #1 Summarized Financials Appendix #2 About HMG Q2 2024 Investor Presentation 4 August 2024
Slide 5: Financial Performance
Financial r : Performance \ Sallie
Slide 6: Key Financial Highlights: Q2-2024
KEY FINANCIAL HIGHLIGHTS : Q2-2024 Revenue by segment SAR million +13.26% Gross profit 13.32% Gross profit Margin Q2-2024 878.03 Q2-2024 34.12% Q2-2023 Q2-2024 SAR (Millions) Q2-2023 774.83 Q2-2023 34.10% 59.85 78.88 2.63% 3.07% 483.71 542.57 21.29% 21.08% EBITDA 10.96% EBITDA margin 2,272.27 2,573.
Slide 7: Key Financial Highlights: H1-2024
KEY FINANCIAL HIGHLIGHTS : H1-2024 Revenue by segment SAR million +11.27% Gross profit 12.63% Gross profit Margin H1-2024 1,755.36 H1-2024 34.45% H1-2023 H1-2024 SAR (Millions) H1-2023 1,558.47 H1-2023 34.03% 122.61 153.66 2.68% 3.02% 974.44 1,086.16 21.28% 21.32% EBITDA 10.16% EBITDA margin 4,579.1
Slide 8: Balance Sheet Highlight
BALANCE SHEET HIGHLIGHT Total assets in H1-23 SAR 13.99 billion vs SAR 17.34 billion in H1-24 Assets Liabilities & Equity ROE ROA Cash & Cash 7.73% 17.43% Current H1-2024 34.04% H1-2024 14.12% equivalents 19.93% 21.15% 6.72% liabilities H1-2023 33.12% H1-2023 15.11% 4.40% Receivable 7.02% 2.80% Inve
Slide 9: Low Leverage Levels
LOW LEVERAGE LEVELS Total liabilities and equity SAR million Total Liabilities/Total Assets Total Liabilities/Equity 120.00% H1-2024 0.59x H1-2024 1.44x H1-2023 0.54x H1-2023 1.17x 100.00% 80.00% 46.09% 40.98% Debt / Equity Net Debt / EBITDA 6,446.97 7,108.46 H1-2024 0.84x H1-2024 1.71x 60.00% H1-20
Slide 10: Total Cash Dividends for Shareholders
TOTAL CASH DIVIDENDS FOR SHAREHOLDERS Declared dividends Declared Cash dividends / Q2 2024 0 50 100 150 200 250 300 350 400 450 Total distributed dividends SAR 409.50 million Q2 2024 SAR 1.17 per share SR 409.5mn 73.8% Payout Q1 2024 SAR 1.17 per share SR 409.5mn 74.3% Payout % of capital 11.70% (eq
Slide 11: Projects Update
Projects Update Q2 2024 Investor Presentation 11 August 2024
Slide 12: Projects Update
PROJECTS UPDATE Solidifying our market Women’s Health Hospital 145 Sehat Al Kharj Hospital 141 Al Muhammadiyah Hospital 350 leadership through robust Expected Riyadh Expected Kharj Expected Jeddah Ownership Ownership Ownership expansion plans and 100% Completion 100% Completion 100% Completion 2024
Slide 13: Operational Highlights
Operational Highlights
Slide 14: Q2 2024 Highlights
Q2 2024 HIGHLIGHTS Key Highlights HMG Mobile Application HMG announced the opening and operation of Sahafa Hospital in north Riyadh. Interaction Habib Live Care Saudi Commission for Health Specialties accredited HMG’s hospitals as the first +157.5 m 20% + 126 k transactions 135% private hospital in
Slide 15: ESG & Sustainability
ESG & SUSTAINABILITY The Group’s ESG structures and targets aim to maximize the benefits we deliver in terms of patient health, the broader contexts of social and human development, and responsible environmental stewardship ESG Roadmap HMG has completed the four-phase exercise undertaken to integrat
Slide 16: Medical Excellence
MEDICAL EXCELLENCE Creating the medical practitioners of the future and promoting health and well-being Research Center Continuous Medical Education Postgraduate Program 1 Journal issued 75+ Activities 130+ Hours 35 25 Published research papers Residency & Fellowship program in 30+ Research pr
Slide 17: Our People
OUR PEOPLE We continue to attract and retain top talent in the Kingdom People Physicians 20,000+ 59% female +36% 4,000+ +95% 15+ average years Employees 41% male Saudization Physicians Retention Rate Experience Staff ratio Physician Qualifications 80+ 120+ recruiting Nationalities offices across the
Slide 18: Investment Proposition
INVESTMENT PROPOSITION Driving sustainable value creation for our stakeholders in the Kingdom and beyond Attractive Industry Adaptable Operating Fundamentals Model Experienced Leadership Solid Performance with Team with Proven Track Long-term Growth Record Potential Market Leader in Medical Excellen
Slide 19: Appendix #1: Summarized Financials
Appendix #1 Summarized Financials
Slide 20: Summary: Balance Sheet
SUMMARY: BALANCE SHEET As of 30 June 2024 SAR million H1-2024 H1-2023 Current Assets 3,755.36 4,303.99 Investment in Associates 198.42 185.93 Investments in equity instruments – Sukuk 300.00 300.00 Property and Equipment 13,090.47 9,198.76 Total Assets 17,344.25 13,988.68 Current Liabilities 3,667.5
Slide 21: Summary: Income Statement
SUMMARY: INCOME STATEMENT As of 30 June 2024 SAR million H1-2024 H1-2023 Change % Revenue 5,095.03 4,579.14 11.27% Cost of revenue (3,339.67) (3,020.67) 10.56% Gross profit 1,755.36 1,558.47 12.63% Selling and marketing expenses (219.85) (184.84) 18.94% General and administrative expenses (427.76) (
Slide 22: Summary: Cash Flow Statement
SUMMARY: CASH FLOW STATEMENT As of 30 June 2024 SAR million H1-2024 H1-2023 Net cash from operating activities 906.94 1,119.70 Net cash used in investing activities (1,973.43) (1,392.19) Net cash from (used in) financing activities (212.80) (35.65) Cash and cash equivalents at the beginning of the y
Slide 23: Appendix #2: About HMG
Appendix #2 About HMG
Slide 24: Where We Operate
WHERE WE OPERATE HMG is committed to improving medical care standards at its existing Kingdom of facilities, expanding its services Saudi Arabia through new ones and creating value NEOM Tabuk for all stakeholders Jubail Industrial City Dammam Bahrain Qassim Khobar Riyadh UAE KAEC Jeddah Kharj MAP KE
Slide 25: Our Strategy
OUR STRATEGY Our well-defined growth strategy enhanced by our core values Our Values Our Pillars Our Priorities Strengthening our core • Attract, develop and empower our people Drivers: Outcomes: • Rigorous quality & safety standards • Patient and customer • Care about patients, communities and the
Slide 26: Key Message
KEY MESSAGE Strategic pillars underpin our drive to deliver best-in-class healthcare services Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare • Technology: Pioneer in healthcare • Efficient cash conversion cycle: provider with 25+ year track record tech
Slide 27: Business Model
BUSINESS MODEL An integrated model of care built for outstanding patient experience and outcomes WHAT HELPS US OUR KEY STRENGTHS WHAT WE DO ACHIEVE OUR GOALS Forefront of Technology and Patient and Customer Centricity for Modern Facilities and Innovation Exceptional Outcomes & Experience Comprehensi
Slide 28: Medical Excellence
MEDICAL EXCELLENCE Medical Operation Strategic Pillars Performance and Efficiency Continuously enhancing the efficient utilization of our resources. Patient Safety Enhancing the safety of our patients at every moment in their journey with HMG Standardization of Care has always been an integral part
Slide 29: Pioneer in Healthcare Technology
PIONEER IN HEALTHCARE TECHNOLOGY Better medical outcomes, exceptional patient experience, and advanced operational practices Tele-medicine Developing cutting edge technology HIS (VIDA) Tele-Cardiology (Nabad 24 program): Designed to 60 Vida implemented sites Pioneer in healthcare technology, award
Slide 30: Diverse Board of Directors
DIVERSE BOARD OF DIRECTORS Our success is driven by our people Non-Executives Executives Independents Dr. Sulaiman Al Habib Group Founder and Mr. Faisal Al Nassar Mr. Obaid Al Rasheed Chairman of the Board of Board member, Group CEO Board member Directors and CFO Mr. Hesham Al Habib Board member and
Slide 31: Committee Members
COMMITTEE MEMBERS Our success is driven by our people Audit Nomination & Executive Patient Safety & Quality Committee Remuneration Committee Committee of Care Committee Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Mr. Mazen Al Rumaih Prof. Mahmoud Al Ahwal Chairman Chairman Chairman Chairman Eng.
Slide 32: Experienced Senior Management
EXPERIENCED SENIOR MANAGEMENT Highly experienced, high caliber management Mr. Faisal Al Nassar CEO & President CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Dr. Abdulwahab Mr. Hesham Al Habib Mr. Saud Al Arifi Al Abdulwahab Chief Business Group General Counsel & Eng. Abdullah Dr. Riyad Al
Slide 33: Thank you
Thank you Dr. Sulaiman Al Habib Medical Services Group Investor Relations Department Telephone: +966 11 525 9999 | Extension: 4919 Mobile: +966 50 338 2785 Email: investor.relations@drsulaimanalhabib.com IR Website: www.hmg.com Q2 2024 Investor Presentation 33 August 2024
Dr. Sulaiman Al Habib Medical Services Group — Q2 2024 Earnings Presentation on 6ix